GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase rlmn (B4TD95)

Analyse AlphaFold monomer V2.0 prediction for dual-specificity RNA methyltransferase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B4TD95
Type
protein
Length
388 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x537a7697cdcd278751bf40d02a88e497634048D7
Molecule
Dual-specificity RNA methyltransferase rlmn
UniProt
B4TD95
Pockets
5 · best druggability 0.83

Structure

1 distinct chain · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual-specificity RNA methyltransferase rlmnprotein38838% helix, 18% strandB4TD95

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11930.830.9732empty
23930.670.8042empty
33680.570.7543empty
4530.440.8416empty
5600.320.7613empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.